Magnetic Resonance Imaging-Based Assessment of Pancreatic Fat Strongly Correlates With Histology-Based Assessment of Pancreas Composition
Overview
Authors
Affiliations
Objective: The aim of the study is to assess the relationship between magnetic resonance imaging (MRI)-based estimation of pancreatic fat and histology-based measurement of pancreatic composition.
Materials And Methods: In this retrospective study, MRI was used to noninvasively estimate pancreatic fat content in preoperative images from high-risk individuals and disease controls having normal pancreata. A deep learning algorithm was used to label 11 tissue components at micron resolution in subsequent pancreatectomy histology. A linear model was used to determine correlation between histologic tissue composition and MRI fat estimation.
Results: Twenty-seven patients (mean age 64.0 ± 12.0 years [standard deviation], 15 women) were evaluated. The fat content measured by MRI ranged from 0% to 36.9%. Intrapancreatic histologic tissue fat content ranged from 0.8% to 38.3%. MRI pancreatic fat estimation positively correlated with microanatomical composition of fat (r = 0.90, 0.83 to 0.95], P < 0.001); as well as with pancreatic cancer precursor ( r = 0.65, P < 0.001); and collagen ( r = 0.46, P < 0.001) content, and negatively correlated with pancreatic acinar ( r = -0.85, P < 0.001) content.
Conclusions: Pancreatic fat content, measurable by MRI, correlates to acinar content, stromal content (fibrosis), and presence of neoplastic precursors of cancer.
Kiemen A, Almagro-Perez C, Matos V, Forjaz A, Braxton A, Dequiedt L bioRxiv. 2024; .
PMID: 39149369 PMC: 11326156. DOI: 10.1101/2024.08.03.606493.
Kiemen A, Wu P, Braxton A, Cornish T, Hruban R, Wood L Sci Adv. 2024; 10(30):eado5103.
PMID: 39058773 PMC: 11277401. DOI: 10.1126/sciadv.ado5103.
PanIN or IPMN? Redefining Lesion Size in 3 Dimensions.
Kiemen A, Dequiedt L, Shen Y, Zhu Y, Matos-Romero V, Forjaz A Am J Surg Pathol. 2024; 48(7):839-845.
PMID: 38764379 PMC: 11189722. DOI: 10.1097/PAS.0000000000002245.
The role of biomarkers in the early detection of pancreatic cancer.
Goggins M Fam Cancer. 2024; 23(3):309-322.
PMID: 38662265 PMC: 11309746. DOI: 10.1007/s10689-024-00381-4.
Forjaz A, Vaz E, Romero V, Joshi S, Braxton A, Jiang A bioRxiv. 2023; .
PMID: 38106231 PMC: 10723352. DOI: 10.1101/2023.12.04.569986.